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Toll-like receptors (TLRs) are cellular receptors that mediate recognition of microbial challenges and the subsequent inﬂammatory
response. Genetic variations within these inﬂammation-associated genes may alter host-pathogen defence mechanisms affecting
susceptibility towards infectious diseases. Taking into account the signiﬁcance of these genes, we developed a simple and rapid method
based in the bi-directional PCR ampliﬁcation of speciﬁc alleles (Bi-PASA) for genotyping known sequence variants in TLR4 (Asp299Gly
and Thr399Ile) and TLR9 (T-1237C) genes. This method allows genotype determination in a single reaction and is amenable to large-
scale analysis. We used Bi-PASA to characterize the distribution of these polymorphisms in the Portuguese population. A total of 388
randomly selected blood donors of Portuguese origin (203 females and 185 males) were genotyped and allele frequencies were
determined. Among the tested individuals, 11.1% and 10.8% were heterozygous for Asp299Gly and Thr399Ile, respectively. In what
concerns the T-1237C variation in TLR9, the variant allele was present in 19.4% of the individuals tested. Besides conﬁrming the
usefulness of the Bi-PASA in polymorphism analysis, the data presented provide valuable information on TLR polymorphisms in the
Portuguese population that can be used to stratify risk patients with increased susceptibility to infection.
r 2007 Elsevier Ltd. All rights reserved.
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The innate immune system is able to recognize conserved
motifs in pathogens in which pattern recognition receptors,
including toll-like receptors (TLRs), play an important role
[1]. TLRs are a family of genetically conserved proteins
identiﬁed as key components of the innate immune system,
mediating recognition of microbial challenges and the
subsequent inﬂammatory response [2]. The ﬁrst of the
currently known TLRs was described in 1997 as a human
homolog of the Drosophila Toll protein, later designated
TLR4 [3]. The complete TLR family allows the host to
detect infection by most, if not all, types of microbial
pathogens. Well characterized receptor–ligand pairs in-
clude TLR4 and lypopolysaccharide (LPS) [4,5], TLR5 and
bacterial ﬂagellin [6], TLR3 and viral double-strandede front matter r 2007 Elsevier Ltd. All rights reserved.
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ess: frodrigues@ecsaude.uminho.pt (F. Rodrigues).DNA [7], TLR9 and bacterial hypomethylated DNA [8]
and TLR2, in association with TLR1 or TLR6, and
a variety of cell wall components from gram-positive
bacteria [9].
Cellular activation via TLRs triggers not only innate
immune responses but also initiates adaptive immunity
[10]. Due to the signiﬁcance of TLRs in the immune
system, genetic variations within these genes could have a
major impact upon host immune response to pathogens
and thus, an increased susceptibility to infection. Regard-
ing TLRs, several polymorphisms are already largely
studied and characterized concerning the phenotypical
outcome, such as polymorphisms in TLR4 [A+896G (SNP
ID: rs4986790) and C+1196T (SNP ID: rs4986791)].
These polymorphisms are located in the coding sequence
resulting in amino acid exchanges: an aspartic acid for a
glycine at position 299 (Asp299Gly) and a threonine for an
isoleucine at position 399 (Thr399Ile), respectively, affect-
ing the extracellular domain of this receptor. Others, such
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Table 1
Summary of association studies between TLR4/TLR9 polymorphisms and infectious and inﬂammation-related diseases
Reference Association study Patients (n) Controls (n) TLR SNP Case vs.
control (%)
p value
Arbour et al. [11] Hyporesponsiveness to
inhaled
lypopolysaccharide
31 57 TLR4 Asp299Gly 22.6 vs 5.8 0.029
Thr399Ile
Lorenz et al. [13] Septic shock 91 73 Asp299Gly 5.5 vs 0 0.05
Lorenz et al. [32] Premature birth
associated to infection
440 351 Asp299Gly 23.8 vs 15.9 0.028
Thr399Ile
Agnese et al. [12] Gram-negative
infections
77 39 Asp299Gly 18.0 vs 12.8 0.004
Thr399Ile
Tal et al. [31] Respiratory synctyal
virus infection
99 82 Asp299Gly 20.2 vs 4.9 0.003
Thr399Ile
Edfeldt et al. [33] Myocardial infarction
associated to infection
1213 1561 Asp299Gly 10.7 vs 7.9 0.004
Thr399Ile
Hawn et al. [34] Legionnaire’s disease 108 510 Asp299Gly 2.5 vs 6.5 0.025
Thr399Ile
Rezazadeh et al. [35] Brucellosis 198 111 Asp299Gly 33.6 vs 20.7 o0.0001
Mockenhaupt et al.
[36]
Severe malaria 70 51 Thr399Ile 24.1 vs 17.6 o0.05
Lazarus et al. [17] Asthma 67 152 TLR9 T-1237C 23.4 vs 14.5 0.042
Torok et al. [18] Crohn’s disease 174 265 T-1237C 19.3 vs 11.9 0.0036
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characterized and their functional importance elucidated.
Among these, the most studied is T-1237C (SNP ID:
rs5743836), a polymorphism located within the putative
promoter region that may inﬂuence transcriptional regula-
tion of the TLR9 gene.
Arbour and colleagues were the ﬁrst to describe that the
two mutations affecting the extracellular domain of TLR4
protein at the 299 and 399 residues were associated with
blunted physiological responses to inhaled lipopolysacchar-
ide [11]. A large number of association studies followed and
the most relevant are summarized in Table 1. Since their
identiﬁcation, these two mutations have been studied for
their association with various infectious and inﬂammatory
diseases. Speciﬁcally, a positive association of the As-
p299Gly mutation with increased susceptibility to Gram-
negative bacteremia and septic shock was found [12,13].
Interestingly however, no association between the As-
p299Gly and/or Thr399Ile mutations was found for other
diseases of infectious etiology, including candidiasis [14],
tuberculosis [15] or meningococcal disease [16]. The varia-
tion T-1237C in the promoter region of TLR9, on the other
hand, has been shown to be associated with an increased
risk for asthma [17] and preliminary data regarding a
possible positive association with Crohn’s disease was also
reported [18]. Nevertheless, some studies also report no
association between this polymorphism and susceptibility to
systemic lupus erythematosus [19] and atopy [20].
Thus, assessment of polymorphisms in TLRs may have a
potential clinically usefulness for risk stratiﬁcation ofpatients possibly more vulnerable to infections. Some of
the previously developed methods are, to a certain extent,
attractive laboratory-tailored approaches for genotyping
polymorphisms in TLR genes, such as the real-time PCR-
based method developed by Hamann et al. [21] or the single
tube PCR reaction based on exonuclease degradation of
allele-speciﬁc probes described by van Rijn et al. [22].
However, most of the genotyping techniques currently
available are still either time-consuming and laborious or
require expensive equipment [23–25]. In this sense, we
adapted a simple and rapid method, allowing genotype
determination in a single reaction based in the bi-
directional PCR ampliﬁcation of speciﬁc alleles (Bi-PASA)
[26] in both the TLR4 (Asp299Gly, Thr399Ile) and TLR9
(T-1237C) genes, a methodology amenable to large scale
analysis, using technology available in most scientiﬁc
laboratories.
2. Materials and methods
Bi-PASA uses a combination of four primers, two outer
primers (named P and Q) and two inner allele-speciﬁc
primers (termed M and W). The inner primers are
characterized by containing a 10-nucleotide G+C-rich 50
tail, which prevents ‘‘megapriming’’ and enhances the
efﬁciency of ampliﬁcation. Depending on the genotype,
Bi-PASA produces two or three overlapping fragments. PQ
is always produced and serves as a positive control. PW
and MQ are present in a heterozygote individual, but PW is
only produced in wild-type homozygote and MQ only in
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PASA were designed following the guidelines proposed by
Liu et al. [26], taking into account both the melting
temperature of both the primers and the largest PCR
segment (PQ). The primers used in this study are shown in
Table 2. The Bi-PASA methodology was optimized using
DNA samples from individuals with known genotype for
the polymorphisms being studied (Fig. 1(B)–(D)). These
samples were previously genotyped by Bergho¨fer et al. and
Hamann et al., using real-time PCR-based methodologies
and conﬁrmed by direct sequencing [20,21].
DNA was isolated from whole blood samples using the
salting-out procedure described by Miller et al. [27] and
PCR ampliﬁcation was performed in a 20 ml volume that
included autoclaved ultra-ﬁltered water, PCR buffer
(1.6 ), dNTP mixture (200 mM each), primers
(0.05–0.4 mM each; for details see Table 2), Taq DNA
polymerase (1 U/20 ml) and approximately 50 ng genomic
DNA templates. PCR cycling conditions included 35 cycles
of 15 s at 94 1C, 30 s at 57 1C, and 45 s at 65 1C, after aFig. 1. Predicted band pattern obtained with Bi-PASA genotyping (A). A
Asp299Gly (B), Thr399Ile (C) and T-1237C (D).
Table 2
Bi-PASA primers used in this study
Gene Polymorphism Primer
TLR4 Asp299Gly P: 50-AGAACTTAAT
Q: 50-GAAAAAGCAT
W: 50-gggccgggggTAC
M: 50-ggcggcggggTTA
Thr399Ile P: 50-CTGGCTGGTT
Q: 50-ATTGAAAGCA
W: 50-gggccgggggAAA
M: 50-ggcggcggggTGA
TLR9 T-1237C P: 50-TCATTCAGCCT
Q: 50-CACATTCAGC
W: 50-ggcggcggggGTG
M: 50-gggccgggggATG10-min initial period of DNA denaturation and enzyme
activation at 94 1C. The ampliﬁed fragments had sizes
readily distinguishable by electrophoresis through a 2%
agarose gel. The results obtained for the genotype of the
Portuguese population by Bi-PASA were further validated
by sequencing analysis of 10 randomly selected samples
(data not shown).
3. Results and discussion
After written informed consent was obtained from each
volunteer, a total of 388 randomly selected blood donors of
Portuguese origin (203 females and 185 males) were
genotyped using Bi-PASA. Among the tested individuals,
43/388 (11.1%) and 42/388 (10.8%) were heterozygous for
Asp299Gly and Thr399Ile polymorphisms, respectively.
None of the individuals showed a homozygous TLR4
polymorphism. In what concerns the T-1237C variation in
TLR9, 67/388 (17.3%) were heterozygous and 8/388
(2.1%) were homozygous for this polymorphism. Basedgarose gel electrophoresis showing results of Bi-PASA genotyping for
Primer ﬁnal concentration
(mM)
GTGGCTCACAAT-30 0.1
TCCCACCTTTG-30 0.1
TACCTCGATGG-30 0.4
AATAAGTCAATAATAT-30 0.4
TAGAAGTCCA-30 0.1
ACTCTGGTGTG-30 0.1
TACTTTAGGCTGT-30 0.1
TTTTGGGACAAT-30 0.1
TCACTCAGA-30 0.4
CCCTAGAGGG-30 0.4
CTGTTCCCTCTGCCTGA-30 0.05
AGACTTGGGGGAGTTTC-30 0.05
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Table 3
Allele frequencies of each TLR polymorphism in distinct ethnic populations [data from Entrez SNP database (http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?CMD=search&DB=snp) in November, 2006] and in our study in the Portuguese population
TLR SNP Allele frequencies
This study European Asian African American Sub-Saharan African
Asp299Gly A 0.889 0.967 1.000 0.848 0.967
G 0.111 0.033 0 0.152 0.033
Thr399Ile C 0.892 0.967 1.000 n/a 1.000
T 0.108 0.033 0 0
T-1237C C 0.806 0.841 0.974 0.750 n/a
T 0.194 0.159 0.026 0.250
n/a—not available.
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studies [28], the two TLR4 polymorphisms, Asp299Gly and
Thr399Ile, are known to be present at an overall allele
frequency of 6.472.8 (range, 0–19.6; n ¼ 38 studies) and
7.273.8 (range, 0–13, n ¼ 11), respectively. However,
reports of differences in the frequencies of these two
polymorphisms among different ethnic groups have been
published [15,29]. In fact, considering the data currently
available on the Entrez SNP database (Table 3), the
frequency of TLR4 Asp299Gly polymorphism is much
higher in African Americans than in Europeans and sub-
Saharan Africans, in contrast to Asians, where this
particular polymorphism does not seem to occur. The
overall frequencies of Thr399Ile are similar to that of
Asp299Gly, although no data is available for African
Americans. African Americans also display a higher
frequency of the TLR9 polymorphism than Europeans
and Asians. Comparing with our results, we can observe
that TLR4 Asp299Gly and Thr399Ile allele frequencies in
the Portuguese population are higher than those described
for the European population characterized in the Entrez
database, although similar to those of controls published in
association studies using European populations. Concern-
ing TLR9, the frequency of T-1237C in the Portuguese
population is similar to the one presented in the database
for the European population. Distributions of both TLR4
and TLR9 genotypes did not deviate from those predicted
by the Hardy-Weinberg equilibrium (Asp299Gly,
p ¼ 0.388; Thr399Ile, p ¼ 0.410; T-1237C, p ¼ 0.58). In
addition and as expected, both TLR4 polymorphisms are
in total linkage disequilibrium (D0 ¼ 1.000). In fact, co-
segregation among these two mutations has also been
largely stated [13,30,31].
In conclusion, the data herein presented provides
valuable information on TLR polymorphisms in the
Portuguese population that can be used in future studies
to stratify patients regarding susceptibility to infection.
Our results clearly show that Bi-PASA is a valuable
methodology for genotyping studies. In addition, this
method can easily be applied in studies of large popula-
tions, and further applied for the study of other poly-
morphisms, as it is a cost-effective technique, where in asingle reaction the genotype of the individuals can be
determined.
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